We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Combined Tests Provide Better Asthma Diagnosis

By LabMedica International staff writers
Posted on 10 Oct 2013
Print article
Image: Three eosinophils in a peripheral blood smear from a patient with eosinophilia (Photo courtesy of Ed Uthman, MD).
Image: Three eosinophils in a peripheral blood smear from a patient with eosinophilia (Photo courtesy of Ed Uthman, MD).
Fraction of exhaled nitric oxide (FENO) and blood eosinophil-count values, markers of local and systemic eosinophilic inflammation, respectively, are increased in asthmatic patients.

Measurement of the concentration of exhaled nitric oxide is today a routine clinical method for determining the degree of steroid-sensitive inflammation in the airways in asthma and for many years, a count of eosinophil granulocytes in the blood has also been used to support a diagnosis of asthma.

Scientists at Uppsala University (Sweden) measured FENO and eosinophil values in 12,408 subjects aged 6 to 80 years from 2007 to 2008 and from 2009 to 2010. Current wheeze and asthma diagnosis, as well as asthma attacks and asthma-related emergency department (ED) visits within the last 12 months, were assessed by means of questionnaires.

The FENO values were measured with the NIOX MINO electrochemical analyzer (Aerocrine AB; Solna, Sweden) at an expiratory flow rate of 50 mL/second. Blood differential counts were performed by using the automated HmX hematology analyzer (Beckman Coulter; Fullerton, CA, USA). The following cutoffs for eosinophil values were used: less than 300 cells/mm3 to define normal values; 300 cells/mm3 or greater but less than 500 cells/mm3 for intermediate values and 500 cells/mm3 or greater for high values, as this is the limit for defining eosinophilia.

The scientists were able to determine that the association between FENO and blood eosinophils was very weak. Instead, they observed that simultaneously elevated levels of the two markers, in a synergistic way, but independently of each other, increased the likelihood of individuals reporting, for example, asthma symptoms or asthma attacks in the last year. The results supported their hypothesis that the two markers represent two different inflammation processes.

Kjell Alving, PhD, a professor at the Department of Children's and Women's Health, Uppsala University, and a senior author of the study said, “We therefore propose that both of these measurements be carried out in combination in order to better understand the inflammation in asthma patients. They thus constitute a better platform for selecting the proper treatment for these patients.” The study was published in the October 2013 issue of the Journal of Allergy and Clinical Immunology.

Related Links:
Uppsala University
Aerocrine AB
Beckman Coulter


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TORCH Infections Test
TORCH Panel
New
Auto Clinical Chemistry Analyzer
cobas c 703

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.